Lab
Physicians Laboratory Services, INC
Physicians Laboratory Services, INC was paid $3.56M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 16% of everything it billed.
33Billing provider infoPHYSICIANS LABORATORY SERVICES, INC
OMAHA, NE 68117
OMAHA, NE 68117
33aNPI1396833026assigned 10/10/2006
33bProvider typeClinical Medical Laboratory
28Total paid$3.56M
24GClaims452,055
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Nebraska
Rank by total paid#1 of 19
Median peer was paid$18K
This provider vs. median194×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70,083 | $542K | |
| 2019 | 65,097 | $421K | |
| 2020 | 65,121 | $563K | |
| 2021 | 89,938 | $795K | |
| 2022 | 103,328 | $895K | |
| 2023 | 52,654 | $310K | |
| 2024incomplete | 5,834 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16% | 10,908 | 8,627 | $579K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.3% | 10,534 | 10,066 | $258K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.2% | 10,524 | 10,054 | $258K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.4% | 46,392 | 41,381 | $157K |
| 80050 | General health panel | 3.8% | 4,974 | 4,791 | $137K |
| 80053 | Comprehensive metabolic panel | 3.5% | 27,923 | 25,946 | $126K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.5% | 17,599 | 16,849 | $123K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.3% | 7,506 | 5,836 | $116K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.1% | 5,000 | 4,828 | $109K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.8% | 6,347 | 6,144 | $101K |
| 87653 | 2.6% | 3,649 | 3,583 | $94K | |
| 80061 | Lipid panel | 2.4% | 14,867 | 14,312 | $85K |
148 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.3% | 19,565 | $81K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 2,871 | $57K |
| 86780 | 1.6% | 6,321 | $57K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 942 | $56K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.5% | 4,494 | $53K |
| 83655 | 1.4% | 5,251 | $50K | |
| 86762 | 1.3% | 4,577 | $47K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 11,952 | $45K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 50,311 | $44K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 14,493 | $42K |
| 87081 | <1% | 7,016 | $35K | |
| 87340 | <1% | 5,108 | $35K | |
| 87660 | <1% | 2,692 | $35K | |
| 87510 | <1% | 2,739 | $34K | |
| 87480 | <1% | 2,737 | $34K | |
| 84439 | <1% | 7,281 | $34K | |
| 87077 | <1% | 8,157 | $32K | |
| 84702 | <1% | 3,387 | $32K | |
| 87186 | <1% | 7,532 | $30K | |
| 86850 | <1% | 4,682 | $29K | |
| 84144 | <1% | 1,799 | $23K | |
| 82728 | <1% | 3,449 | $22K | |
| 86803 | <1% | 2,577 | $21K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 521 | $20K |
| 87070 | <1% | 3,959 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,493 | $18K |
| 82607 | <1% | 2,856 | $17K | |
| 84403 | <1% | 1,182 | $17K | |
| 86003 | <1% | 551 | $15K | |
| 81001 | <1% | 9,695 | $15K | |
| 82670 | <1% | 848 | $13K | |
| 82950 | <1% | 3,624 | $12K | |
| 83516 | <1% | 786 | $12K | |
| 83001 | <1% | 1,059 | $11K | |
| 85027 | <1% | 4,038 | $11K | |
| 83540 | <1% | 3,594 | $10K | |
| 86140 | <1% | 3,610 | $10K | |
| 86900 | <1% | 4,650 | $10K | |
| 86901 | <1% | 4,659 | $9K | |
| 86787 | <1% | 1,021 | $9K | |
| 87147 | <1% | 2,236 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 298 | $9K |
| 87205 | <1% | 3,548 | $8K | |
| 82570 | <1% | 3,295 | $8K | |
| 83550 | <1% | 2,066 | $8K | |
| 84481 | <1% | 851 | $8K | |
| 84146 | <1% | 721 | $8K | |
| 85018 | <1% | 4,416 | $8K | |
| 83880 | <1% | 657 | $8K | |
| 83970 | <1% | 491 | $7K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 183 | $7K |
| 80074 | <1% | 287 | $7K | |
| 82784 | <1% | 911 | $7K | |
| 80164 | <1% | 1,687 | $6K | |
| 84270 | <1% | 499 | $6K | |
| 84466 | <1% | 923 | $6K | |
| 81025 | <1% | 1,006 | $6K | |
| 83002 | <1% | 493 | $6K | |
| 82746 | <1% | 879 | $5K | |
| 80081 | <1% | 145 | $5K | |
| 84153 | <1% | 598 | $5K | |
| 85610 | <1% | 4,821 | $5K | |
| 86038 | <1% | 656 | $5K | |
| 80076 | <1% | 1,320 | $4K | |
| 85652 | <1% | 2,990 | $4K | |
| 82043 | <1% | 1,772 | $4K | |
| 83735 | <1% | 1,430 | $4K | |
| 84156 | <1% | 1,820 | $4K | |
| 82785 | <1% | 312 | $4K | |
| 82247 | <1% | 1,100 | $4K | |
| 86376 | <1% | 373 | $3K | |
| 87210 | <1% | 967 | $3K | |
| 86696 | <1% | 263 | $3K | |
| 81003 | <1% | 2,826 | $3K | |
| 82105 | <1% | 262 | $3K | |
| 83690 | <1% | 708 | $3K | |
| 87631 | <1% | 40 | $3K | |
| 86694 | <1% | 138 | $2K | |
| 82951 | <1% | 276 | $2K | |
| 84165 | <1% | 531 | $2K | |
| 86235 | <1% | 136 | $2K | |
| 84550 | <1% | 971 | $2K | |
| 82533 | <1% | 222 | $2K | |
| 86695 | <1% | 259 | $2K | |
| 83615 | <1% | 659 | $2K | |
| 86364 | <1% | 355 | $2K | |
| 86480 | <1% | 39 | $2K | |
| 82550 | <1% | 490 | $2K | |
| 86431 | <1% | 472 | $2K | |
| 86800 | <1% | 157 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 107 | $1K |
| 84703 | <1% | 224 | $1K | |
| 82150 | <1% | 324 | $1K | |
| 87493 | <1% | 41 | $1K | |
| 82465 | <1% | 346 | $1K | |
| 82248 | <1% | 385 | $1K | |
| 86160 | <1% | 161 | $1K | |
| 83013 | <1% | 29 | $986.17 | |
| 82952 | <1% | 277 | $852.59 | |
| 80178 | <1% | 311 | $823.07 | |
| 84100 | <1% | 396 | $756.11 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 115 | $680.96 |
| 87075 | <1% | 157 | $654.53 | |
| 87899 | <1% | 33 | $647.62 | |
| 86256 | <1% | 85 | $597.93 | |
| 83520 | <1% | 43 | $566.44 | |
| 86258 | <1% | 72 | $560.69 | |
| 86706 | <1% | 90 | $557.78 | |
| 86308 | <1% | 123 | $553.03 | |
| 87625 | <1% | 39 | $546.58 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 27 | $505.27 |
| 85014 | <1% | 362 | $500.28 | |
| 82947 | <1% | 196 | $425.48 | |
| 85730 | <1% | 121 | $388.99 | |
| 82627 | <1% | 26 | $359.92 | |
| 86039 | <1% | 54 | $349.56 | |
| 86769 | <1% | 15 | $345.47 | |
| 86200 | <1% | 41 | $339.90 | |
| 87088 | <1% | 129 | $327.21 | |
| 86665 | <1% | 13 | $290.95 | |
| 86335 | <1% | 17 | $278.84 | |
| 86304 | <1% | 28 | $278.69 | |
| 87046 | <1% | 32 | $241.73 | |
| 87045 | <1% | 32 | $241.73 | |
| 84145 | <1% | 14 | $239.51 | |
| 81015 | <1% | 115 | $221.83 | |
| 80185 | <1% | 51 | $212.11 | |
| 82378 | <1% | 27 | $208.39 | |
| 85379 | <1% | 29 | $198.98 | |
| 84166 | <1% | 17 | $169.39 | |
| 82977 | <1% | 47 | $152.06 | |
| 82239 | <1% | 14 | $130.79 | |
| 87420 | <1% | 12 | $130.78 | |
| 86664 | <1% | 13 | $122.59 | |
| 86663 | <1% | 13 | $105.20 | |
| 84478 | <1% | 27 | $88.29 | |
| 83521 | <1% | 14 | $82.88 | |
| 82310 | <1% | 30 | $61.29 | |
| 86704 | <1% | 12 | $50.39 | |
| 84155 | <1% | 40 | $49.90 | |
| 84436 | <1% | 13 | $43.14 | |
| 87184 | <1% | 13 | $37.42 | |
| 84132 | <1% | 30 | $35.85 | |
| 86592 | <1% | 12 | $33.73 | |
| 80069 | <1% | 27 | $29.62 | |
| 85045 | <1% | 14 | $24.27 | |
| 87168 | <1% | 14 | $13.70 | |
| 87634 | 0% | 149 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROFFMAN, BLAINE (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Physicians Laboratory, PC | Omaha, NE | $465K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.